1. MARKETS
  2. SECTOR : OTHERS
  3. INDUSTRY : OTHERS
  4. TELOMIR PHARMACEUTICALS INC
Telomir Pharmaceuticals Inc XNAS: TELO
Download real time
1.16 -0.01 (-0.85%)
New 52W Low today
155.8K
XNAS Volume

XNAS 11 Jul, 2025 5:30 PM (EDT)

Watchlist

Portfolio

Alert

Share
Board Meeting
The next board meeting for Telomir Pharmaceuticals Inc is on 16 Jul 2025 for the purpose of Telomir Pharmaceuticals Inc Annual General Meeting for 2024 See details


Insider Trading disclosures for Telomir Pharmaceuticals Inc

The latest disclosure was made by Erez Aminov in Telomir Pharmaceuticals Inc where a trade of 2,000,000 Non-Qualified Options done was reported to US exchanges on May 28, 2025.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Erez Aminov Director, CEO and Chairman Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 May 2025 2,000,000 2,000,000 - - Non-Qualified Options
Erez Aminov Director, CEO and Chairman Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 May 2025 400,000 400,000 - - Restricted Stock Units (RSUs)
Erez Aminov Director, CEO and Chairman 31 Dec 2024 200 29,600 - 6.0 1,202 Common Stock
Erez Aminov Director, CEO and Chairman 31 Dec 2024 200 29,600 - 6.2 1,240 Common Stock
Michael Jerman Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Aug 2024 25,000 25,000 - - Incentive Stock Options (right to buy)
Matthew Pratt Whalen Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Aug 2024 25,000 25,000 - - Incentive Stock Options (right to buy)
Michelle Yanez Chief Financial Officer 27 Aug 2024 200,000 200,000 - - Incentive Stock Options (right to buy)
Matthew Paul Del Giudice Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Aug 2024 25,000 25,000 - - Incentive Stock Options (right to buy)
Erez Aminov Director, CEO & Chairman Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Aug 2024 1,960,170 1,960,170 - - Incentive Stock Options (right to buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures
Screeners based on Insider Trading and SAST parameters